These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35938011)

  • 21. Mandatory newborn screening in the United States: History, current status, and existential challenges.
    McCandless SE; Wright EJ
    Birth Defects Res; 2020 Mar; 112(4):350-366. PubMed ID: 32115905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges for Worldwide Harmonization of Newborn Screening Programs.
    Martínez-Morillo E; Prieto García B; Álvarez Menéndez FV
    Clin Chem; 2016 May; 62(5):689-98. PubMed ID: 27001491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn screening in the genomics era.
    Rego S
    J Law Biosci; 2014 Sep; 1(3):369-377. PubMed ID: 27774176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot.
    Hartnett MJ; Lloyd-Puryear MA; Tavakoli NP; Wynn J; Koval-Burt CL; Gruber D; Trotter T; Caggana M; Chung WK; Armstrong N; Brower AM
    Int J Neonatal Screen; 2022 Sep; 8(4):. PubMed ID: 36278620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systems Integration: The Next Frontier in Newborn-Screening Timeliness.
    Simon NJ; Atkins A; Yusuf C; Tarini BA
    J Public Health Manag Pract; 2020; 26(6):E8-E15. PubMed ID: 30789598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Long-Term Follow-Up Data to Classify Genetic Variants in Newborn Screened Conditions.
    Wilhelm K; Edick MJ; Berry SA; Hartnett M; Brower A
    Front Genet; 2022; 13():859837. PubMed ID: 35692825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newborn Screening for Pompe Disease.
    Bodamer OA; Scott CR; Giugliani R;
    Pediatrics; 2017 Jul; 140(Suppl 1):S4-S13. PubMed ID: 29162673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Check: translational science at the intersection of public health and newborn screening.
    Bailey DB; Gehtland LM; Lewis MA; Peay H; Raspa M; Shone SM; Taylor JL; Wheeler AC; Cotten M; King NMP; Powell CM; Biesecker B; Bishop CE; Boyea BL; Duparc M; Harper BA; Kemper AR; Lee SN; Moultrie R; Okoniewski KC; Paquin RS; Pettit D; Porter KA; Zimmerman SJ
    BMC Pediatr; 2019 Jul; 19(1):238. PubMed ID: 31315600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newborn screening for lysosomal diseases: current status and potential interface with population medical genetics in Latin America.
    Giugliani R
    J Inherit Metab Dis; 2012 Sep; 35(5):871-7. PubMed ID: 22231381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ScreenPlus: A comprehensive, multi-disorder newborn screening program.
    Kelly NR; Orsini JJ; Goldenberg AJ; Mulrooney NS; Boychuk NA; Clarke MJ; Paleologos K; Martin MM; McNeight H; Caggana M; Bailey SM; Eiland LR; Ganesh J; Kupchik G; Lumba R; Nafday S; Stroustrup A; Gelb MH; Wasserstein MP
    Mol Genet Metab Rep; 2024 Mar; 38():101037. PubMed ID: 38173711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up data collection and use in state newborn screening programs.
    Hoff T; Ayoob M; Therrell BL
    Arch Pediatr Adolesc Med; 2007 Oct; 161(10):994-1000. PubMed ID: 17909144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parental Attitudes Toward Standard Newborn Screening and Newborn Genomic Sequencing: Findings From the BabySeq Study.
    Armstrong B; Christensen KD; Genetti CA; Parad RB; Robinson JO; Blout Zawatsky CL; Zettler B; Beggs AH; Holm IA; Green RC; McGuire AL; Smith HS; Pereira S;
    Front Genet; 2022; 13():867371. PubMed ID: 35571041
    [No Abstract]   [Full Text] [Related]  

  • 34. Parental Preferences for Expanded Newborn Screening: What Are the Limits?
    Liang NSY; Watts-Dickens A; Chitayat D; Babul-Hirji R; Chakraborty P; Hayeems RZ
    Children (Basel); 2023 Aug; 10(8):. PubMed ID: 37628361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol.
    Milko LV; Rini C; Lewis MA; Butterfield RM; Lin FC; Paquin RS; Powell BC; Roche MI; Souris KJ; Bailey DB; Berg JS; Powell CM
    Trials; 2018 Jun; 19(1):344. PubMed ID: 29950170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Including ELSI research questions in newborn screening pilot studies.
    Goldenberg AJ; Lloyd-Puryear M; Brosco JP; Therrell B; Bush L; Berry S; Brower A; Bonhomme N; Bowdish B; Chrysler D; Clarke A; Crawford T; Goldman E; Hiner S; Howell RR; Orren D; Wilfond BS; Watson M;
    Genet Med; 2019 Mar; 21(3):525-533. PubMed ID: 30100612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of expanded newborn screening--United States, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(37):1012-5. PubMed ID: 18802410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Policy Making in Newborn Screening Needs a Structured and Transparent Approach.
    Jansen ME; Lister KJ; van Kranen HJ; Cornel MC
    Front Public Health; 2017; 5():53. PubMed ID: 28377917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Follow-Up Cares and Check Initiative: A Program to Advance Long-Term Follow-Up in Newborns Identified with a Disease through Newborn Screening.
    Lietsch M; Chan K; Taylor J; Lee BH; Ciafaloni E; Kwon JM; Waldrop MA; Butterfield RJ; Rathore G; Veerapandiyan A; Kapil A; Parsons JA; Gibbons M; Brower A
    Int J Neonatal Screen; 2024 Apr; 10(2):. PubMed ID: 38651399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders.
    Osara Y; Coakley K; Devarajan A; Singh RH
    Orphanet J Rare Dis; 2017 Jul; 12(1):132. PubMed ID: 28724394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.